Commentary on a case involving a 34-year-old woman who presented twice to the same ED for evaluation of symptoms of an allergic reaction.
Key clinical point: Almost all patients treated at EDs for nonfatal opioid overdose continue to receive opioid prescriptions. Major finding: 2,597...
Key clinical point: Efforts to encourage safer prescribing of opioid pain relievers should be strengthened. Major finding: In 2014, opioids were...
Contrary to reports that a relative few physicians prescribe most opioids, many primary care providers and specialists prescribe such painkillers...
“Just a small amount of this stuff can injure or even kill a small child. Making these bottles childproof is just common sense,” according to the...
Newly approved naloxone nasal spray can revive opioid addicts who have overdosed, but only effective treatment can save them.
A 37-year-old woman was brought to the ED after developing acute confusion, agitation, and hallucinations during an outpatient tumescent...
The Food and Drug Administration has approved Narcan, a naloxone nasal spray used to stop or reverse the effects of opioid overuse.
Two children who had ingested aripiprazole but not amphetamines tested positive for amphetamine use in urine drug screens performed within 24...